6-Amino-5-bromoquinoxaline is a heterocyclic intermediate that typically used in the preparation of Brimonidine (AGN-190342), an α2-adrenoceptor agonist.
The evolving pharmacotherapeutic profile of brimonidine, an alpha 2-adrenergic agonist, after four years of continuous use. [1]
New series of N-aryl- and N-heteroaryl-d-glucuronamides as potential anticancer agents: Synthesis and spectroscopic analysis. [2]
